Hai cercato la traduzione di idelalisib da Croato a Inglese

djelatna tvar je idelalisib.
the active substance is idelalisib.

idelalisib u kombinaciji s ofatumumabom
idelalisib in combination with ofatumumab

zydelig sadrži djelatnu tvar idelalisib.
zydelig contains the active substance idelalisib.

zydelig 100 mg filmom obložene tablete idelalisib
zydelig 100 mg film-coated tablets idelalisib

idelalisib se može uzimati bez obzira na hranu.
idelalisib can be administered without regard to food.

idelalisib se ne smije istovremeno primjenjivati s alfuzosinom.
idelalisib should not be co-administered with alfuzosin.

idelalisib se uzimao do progresije bolesti ili neprihvatljive toksičnosti.
idelalisib was taken until disease progression or unacceptable toxicity.

idelalisib je izazvao upalne promjene i u štakora i u pasa.
idelalisib induced inflammatory changes in both rats and dogs.

idelalisib i gs-563117 su supstrati za p-gp i bcrp.
idelalisib and gs-563117 are substrates of p-gp and bcrp.

na temelju nalaza u životinja, idelalisib može uzrokovati oštećenje fetusa.
based on findings in animals, idelalisib may cause foetal harm.

nije poznato izlučuju li se idelalisib i njegovi metaboliti u majčino mlijeko.
it is not known whether idelalisib and its metabolites are excreted in human milk.

idelalisib nije ispitan u pacijenata s kroničnim aktivnim hepatitisom, uključujući virusni hepatitis.
idelalisib has not been studied in patients with chronic active hepatitis including viral hepatitis.

idelalisib je u štakora pokazao mogućnost inhibicije imunološkog odgovora protutijelima ovisnog o t limfocitima.
in rats, idelalisib has the potential to inhibit t-dependent antibody responses.

djelatna tvar lijeka zydelig, idelalisib, inhibira djelovanje enzima naziva pi3k-delta.
the active substance in zydelig, idelalisib, blocks the effects of an enzyme called pi3k-delta.

ako ste alergični na idelalisib ili neki drugi sastojak ovog lijeka (naveden u dijelu 6).
do not take zydelig if you are allergic to idelalisib or any of the other ingredients of this medicine (listed in section 6).

tablica 2: nuspojave zabilježene u kliničkim ispitivanjima u ispitanika s hematološkim zloćudnim bolestima koji su primali idelalisib
table 2: adverse drug reactions reported in clinical studies in subjects with haematologic malignancies receiving idelalisib

idelalisib inducira apoptozu i inhibira proliferaciju staničnih linija dobivenih iz zloćudnih b-stanica te primarnih tumorskih stanica.
idelalisib induces apoptosis and inhibits proliferation in cell lines derived from malignant b-cells and in primary tumour cells.

in vitro, idelalisib je i inhibirao i inducirao cyp2c8, ali nije poznato prenosi li se to na in vivo učinak na cyp2c8 supstrate.
in vitro, idelalisib both inhibited and induced cyp2c8, but it is not known whether this translates to an in vivo effect on cyp2c8 substrates.

trenutno nije poznato može li idelalisib smanjiti učinkovitost hormonske kontracepcije pa stoga žene koje uzimaju hormonsku kontracepciju trebaju dodatno koristiti i barijernu metodu kao drugi oblik kontracepcije.
it is currently unknown whether idelalisib may reduce the effectiveness of hormonal contraceptives, and therefore women using hormonal contraceptives should add a barrier method as a second form of contraception.

budući da trenutno nije poznato može li idelalisib smanjiti učinkovitost hormonske kontracepcije, žene koje uzimaju hormonsku kontracepciju trebaju dodatno koristiti i barijernu metodu kao drugi oblik kontracepcije.
women using hormonal contraceptives should add a barrier method as a second form of contraception since it is currently unknown whether idelalisib may reduce the effectiveness of hormonal contraceptives.